Related references
Note: Only part of the references are listed.Access to Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma
Sophie Snyder et al.
ADVANCES IN THERAPY (2021)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Building a Program Implications for infrastructure, nursing education, and training for CAR T-cell therapy
Lenise Taylor et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2019)
Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center
Karlo Perica et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Time Is Money: Investigating the Value of Leisure Time and Unpaid Work
Kaya Verbooy et al.
VALUE IN HEALTH (2018)
The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey
M. Kelsey Kirkwood et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
E. Van den Neste et al.
BONE MARROW TRANSPLANTATION (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer
Amol K. Narang et al.
JAMA ONCOLOGY (2017)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships
Matthew P. Banegas et al.
HEALTH AFFAIRS (2016)
Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer
Scott D. Ramsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review
Charlotte Kelly et al.
BMJ OPEN (2016)
Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US
J. Mark Stephens et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy
Jordina Rovira et al.
ANNALS OF HEMATOLOGY (2015)
Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis
Scott Ramsey et al.
HEALTH AFFAIRS (2013)
The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience
S. Yousuf Zafar et al.
ONCOLOGIST (2013)
Inequity in access to cancer care: a review of the Canadian literature
Andre R. Maddison et al.
CANCER CAUSES & CONTROL (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma
Arturo Molina
ANNUAL REVIEW OF MEDICINE (2008)
Focused factories? Physician-owned specialty facilities
LP Casalino et al.
HEALTH AFFAIRS (2003)
Share Paper
